MedPath

Identification of new biological markers for the evaluation of different effects of thyroid hormones on different tissues

Phase 1
Conditions
Women with dysregulated hypothyroidism
Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Registration Number
EUCTR2017-003673-34-NO
Lead Sponsor
Oslo University Hospital, Department of Endocrinologi, Morbid Obesity and Preventive Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women with poorly regulated hypothyroidism defined as subjective feeling of cold intolerance, fatigue, cognitive- and memory-related problems despite adequate thyroxine (Levaxin) therapy, age between 18-65
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Cardiovascular disease, liver disease, other endocrinological disease (diabetes mellitus Mb. Addison, hypopituitarism), hormonal substitution therapy beyond T4 and T3, psychiatric disease

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath